Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Others
    (3)
Filter
Search Result
Results for "

toos

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | Inhibitors_Agonists
  • Natural Products
    2
    TargetMol | Natural_Products
  • Cell Research
    2
    TargetMol | Inhibitors_Agonists
TOOS
TOOS sodium salt
T1958582692-93-1
TOOS is a novel highly water-soluble aniline derivative and is widely used in diagnostic tests and biochemical tests.
  • $51
7-10 days
Size
QTY
Toosendanin
T6S023458812-37-6
1. Toosendanin possesses hepatotoxicity. 2. Toosendanin has effects on the growth, cell cycle arrest, induction of apoptosis and the involved signaling pathway in human promyelocytic leukemia HL-6 cells. 3. Toosendanin is an effective insecticide for Ae.
  • $40
In Stock
Size
QTY
Isotoosendanin
(1S,2S,4R,5S,6R,9S,10S,11R,13R,18S,20R)-20-(acetyloxy)-6-(furan-3-yl)-11,15,18-trihydroxy-5,10,14-trimethyl-3,8-dioxo-16-oxapentacyclo[12.3.3.01,13.02,1?.0?,?]icosan-4-yl acetate
TN698997871-44-8
Isotoosendanin ((1S,2S,4R,5S,6R,9S,10S,11R,13R,18S,20R)-20-(acetyloxy)-6-(furan-3-yl)-11,15,18-trihydroxy-5,10,14-trimethyl-3,8-dioxo-16-oxapentacyclo[12.3.3.01,13.02,1?.0?,?]icosan-4-yl acetate) is a limonoid isolated from Melia toosendan fruit with anti-inflammatory and analgesic capacity.
  • $29
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Toosendanin-OVA
TYD-01613
Toosendanin OVA is an antigen-adjuvant conjugate of Toosendanin and ovalbumin (OVA). This conjugation enhances the production of antigen-specific antibodies in vaccine models by linking the antigen to a protein adjuvant. The conjugate does not alter protein folding or disrupt major epitopes, and it improves cross-presentation and the generation of antigen-specific T cells.
  • Inquiry Price
Inquiry
Size
QTY
Toosendanin-BSA
TYD-01614
Toosendanin BSA is an antigen-adjuvant conjugate of Toosendanin and bovine serum albumin (BSA). The conjugation of the antigen with the protein adjuvant can enhance the production of antigen-specific antibodies in vaccine models. This conjugate does not affect protein folding or disrupt major epitopes and can increase cross-presentation and the generation of antigen-specific T cells.
  • Inquiry Price
Inquiry
Size
QTY